Bormioli Pharma, a provider of comprehensive packaging solutions for injectable drugs, announced robust growth in its North American business in 2022, with sales increasing more than 40% year-over-year. The growth in North America was matched by strong sales gains in the company’s markets worldwide, reflecting Bormioli’s multimillion dollar investments in expanding its capabilities as a provider of comprehensive packaging solutions for injectable drugs. “For almost 200 years, we have been ...